Figure 1.
Distribution of the respective disease modifying therapies among the published SARS-CoV-2 positive multiple sclerosis patients. COVID-19: coronavirus disease 2019; DMF: dimethyl-fumarate; MS: multiple sclerosis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.